La Utilidad de las Herramientas de Evaluación de Reacciones Adversas a Medicamentos de Liverpool en la Evaluación de Náuseas y Vómitos Inducidos por Quimioterapia en Niños
DOI:
https://doi.org/10.32635/2176-9745.RBC.2023v69n3.3986Palabras clave:
efectos colaterales y reacciones adversas relacionados con medicamentos, náusea, vómitos, neoplasias, niñoResumen
Introducción: Las náuseas y vómitos inducidos por quimioterapia (NVIQ) son reacciones adversas a medicamentos (RAM) comunes en niños en tratamiento oncológico. Nuevas herramientas de Evaluación de Causalidad y Evitabilidad de RAM de Liverpool (LCAT y LAAT) han sido validadas y ayudan en la categorización de factores de riesgo. Sin embargo, ningún estudio ha comparado su utilidad y resultados para evaluación de NVIQ en países con diferentes niveles de desarrollo. Objetivo: Investigar la utilidad de LCAT y LAAT en la evaluación de NVIQ. Método: Estudio observacional prospectivo con niños de 4 a 16 años del Alder Hey Children’s Hospital (Liverpool, Reino Unido) y del Instituto de Pediatría Martagão Gesteira (Río de Janeiro, Brasil). Los niños (ayudados por los padres) completaron un diario de síntomas durante y hasta 24 horas después de la quimioterapia. La información sobre el diagnóstico subyacente, la historia médica previa y los medicamentos se recopiló de la historia clínica médico del paciente. Se prepararon informes de casos y se registró la relación temporal entre las RAM y la exposición a la quimioterapia, incluyendo cualquier estrategia para prevenir NVIQ, para análisis de causalidad y evitabilidad con LCAT y LAAT, respectivamente. Resultados: Hubo 26 notificaciones de NVIQ en 36 ciclos de quimioterapia. La causalidad fue “definida” para 24 casos. Fueron consideradas “definitivamente evitables” 20 RAM y “no evitables”, cuatro. La selección de opciones terapéuticas inadecuadas y la omisión de antieméticos fueron los principales problemas evitables. Conclusión: LCAT y LAAT fueron útiles para evaluar NVIQ en niños en dos países diferentes.
Descargas
Citas
Van Laar ES, Desai JM, Jatoi A. Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2388 health care providers. Support Care Cancer. 2015;23(1):151-7. doi: https://doi.org/10.1007/s00520-014-2325-x DOI: https://doi.org/10.1007/s00520-014-2325-x
Phillips RS, Friend AJ, Gibson F, et al. Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood. Cochrane Database of Syst Rev. 2016;2(2):CD007786. doi: https://doi.org/10.1002/14651858.CD007786.pub3 DOI: https://doi.org/10.1002/14651858.CD007786.pub3
Patel H, Gurumurthy P. Improving medication safety in oncology care: impact of clinical pharmacy interventions on optimizing patient safety. Int J Clin Pharm. 2019;41(4):981-92. doi: https://doi.org/10.1007/s11096-019-00860-0 DOI: https://doi.org/10.1007/s11096-019-00860-0
Evans A, Vingelen MB, Yu C, et al. Nausea in numbers: electronic medical record nausea and vomiting assessment for children with cancer. J Pediatr Oncol Nurs. 2020;37(3):195-203. doi: https://doi.org/10.1177/1043454219900467 DOI: https://doi.org/10.1177/1043454219900467
Antonarakis ES. Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice. Arch Dis Child. 2004;89(9):877-80. doi: https://doi.org/10.1136/adc.2003.037341 DOI: https://doi.org/10.1136/adc.2003.037341
Uppsala Monitoring Centre [Internet]. Sweden: Uppsala Monitoring Centre; [cited 2023 Mar 23]. Available from: https://who-umc.org/
Anderson BJ, Lerman J, Coté CJ. Pharmacokinetics and Pharmacology of drugs used in children. In: Coté CJ, Lerman J, Anderson BJ, editors. A practice of anesthesia for infants and children [Internet]. Philadelphia (PA): Elsevier; 2019 [cited 2023 Mar 23]. p. 100-176.e45. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780323429740000070 DOI: https://doi.org/10.1016/B978-0-323-42974-0.00007-0
Gallagher RM, Kirkham JJ, Mason JR, et al. Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. PLoS One. 2011;6(12):e28096. doi: https://doi.org/10.1371/journal.pone.0028096 DOI: https://doi.org/10.1371/journal.pone.0028096
Bracken LE, Nunn AJ, Kirkham JJ, et al. Development of the Liverpool adverse drug reaction avoidability assessment tool. PLoS One. 2017;12(1):e0169393. doi: https://doi.org/10.1371/journal.pone.0169393 DOI: https://doi.org/10.1371/journal.pone.0169393
Olsson S, Pal SN, Dodoo A. Pharmacovigilance in resource-limited countries. Expert Rev Clin Pharmacol. 2015;8(4):449-60. doi: https://doi.org/10.1586/17512433.2015.1053391 DOI: https://doi.org/10.1586/17512433.2015.1053391
Aapro M, Jordan K, Feyer P. Prevention of nausea and vomiting in cancer patients [Internet]. London: Springer Healthcare; c2013 [cited 2023 Mar 23]. Available from: https://link.springer.com/book/10.1007/978-1-907673-58-0 DOI: https://doi.org/10.1007/978-1-907673-58-0
Paw Cho Sing E, Robinson PD, Flank J, et al. Classification of the acute emetogenicity of chemotherapy in pediatric patients: a clinical practice guideline. Pediatr Blood Cancer. 2019;66(5):e27646. doi: https://doi.org/10.1002/pbc.27646 DOI: https://doi.org/10.1002/pbc.27646
Patel P, Robinson PD, Thackray J, et al. Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: a focused update. Pediatr Blood Cancer. 2017;64(10):e26542. doi: https://doi.org/10.1002/pbc.26542 DOI: https://doi.org/10.1002/pbc.26542
Dupuis LL, Sung L, Molassiotis A, et al. 2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children. Support Care Cancer. 2017;25(1):323-31. doi: https://doi.org/10.1007/s00520-016-3384-y DOI: https://doi.org/10.1007/s00520-016-3384-y
Mazlum S, Chaharsoughi NT, Banihashem A, et al. The effect of massage therapy on chemotherapy-induced nausea and vomiting in pediatric cancer. Iran J Nurs Midwifery Res. 2013;18(4):280-4. Cited in: PubMed; PMID: 24403922.
Smyth RL, Peak M, Turner MA, et al. ADRIC: Adverse Drug Reactions In Children – a programme of research using mixed methods. Programme Grants Appl Res. 2014;2(3):1-184. doi: https://doi.org/10.3310/pgfar02030 DOI: https://doi.org/10.3310/pgfar02030
Thiesen S, Conroy EJ, Bellis JR, et al. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions. BMC Med. 2013;11:237. doi: https://doi.org/10.1186/1741-7015-11-237 DOI: https://doi.org/10.1186/1741-7015-11-237
Conselho Nacional de Saúde (BR). Resolução nº 466, de 12 de dezembro de 2012. Aprova as diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Diário Oficial da União, Brasília, DF. 2013 jun 13; Seção 1:59.
Beauchemin M, Sung L, Hershman DL, et al. Guideline concordant care for prevention of acute chemotherapy-induced nausea and vomiting in children, adolescents, and young adults. Support Care Cancer. 2020;28(10):4761-9. doi: https://doi.org/10.1007/s00520-020-05310-6 DOI: https://doi.org/10.1007/s00520-020-05310-6
Bellare PS, Ashwin K, Prakash PU S, et al. A retrospective evaluation of adverse drug reactions due to cancer chemotherapy in a tertiary care hospital in south India. J Young Pharm. 2016;8(3):251-4. doi: https://doi.org/10.5530/jyp.2016.3.14 DOI: https://doi.org/10.5530/jyp.2016.3.14
Children’s Cancer and Leukaemia Group [Internet]. Leicester (UK): CCLG; [date unknown]. Chemotherapy induced nausea and vomiting; [cited 2021 Dec 2]. Available from: https://www.cclg.org.uk/CSOIR/Chemotherapy-induced-nausea-and-vomiting
Fornasier G, Taborelli M, Francescon S, et al. Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance. Int J Clin Pharm. 2018;40(4):795-802. doi: https://doi.org/10.1007/s11096-018-0653-5 DOI: https://doi.org/10.1007/s11096-018-0653-5
Abunahlah N, Sancar M, Dane F, et al. Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life. Int J Clin Pharm. 2016;38(6):1464-76. doi: https://doi.org/10.1007/s11096-016-0393-3 DOI: https://doi.org/10.1007/s11096-016-0393-3
Organisation for Economic Cooperation and Development; World Health Organization, World Bank Group. Delivering quality health services: a global imperative. Geneva: WHO; 2018.
França MS, Usón Junior PLS, Antunes YPPV, et al. Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy. Einstein (São Paulo). 2015;13(2):221-5. doi: https://doi.org/10.1590/S1679-45082015AO3097 DOI: https://doi.org/10.1590/S1679-45082015AO3097
Elshafie S, Zaghloul I, Roberti AM. Pharmacovigilance in developing countries (part I): importance and challenges. Int J Clin Pharm. 2018;40(4):758-63. doi: https://doi.org/10.1007/s11096-017-0570-z DOI: https://doi.org/10.1007/s11096-017-0570-z
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
